The Covid-19 pandemic has brought a laser focus to the critical and immediate need for next-generation sequencing tools that can generate invaluable data for not only identifying emerging variants but for understanding the functional and epidemiological consequences of variant-specific mutations.
As part of a new initiative called DNA10K, more than 10,000 NorthShore patients will gain access to Color's clinical-grade genetic testing and whole genome sequencing.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
A Chinese genomics startup will be using Illumina's Hi-Seq X Ten machines to provide highly detailed ancestry information, direct to consumers.